Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system

British Journal of Pharmacology

Volumn 148, Issue 6, 2006, Pages 833-844

  Zhu, Ying ^a,b   Yao, Jian ^a   Meng, Yiman ^a   Kasai, Ayumi ^a   Hiramatsu, Nobuhiko ^a   Hayakawa, Kunihiro ^a   Miida, Takashi ^b   Takeda, Masayuki ^a   Okada, Masahiko ^b   Kitamura, Masanori ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Apoptosis; cAMP; Mesangial cell; Phosphodiesterase (PDE); Secreted alkaline phosphatase (SEAP)

Indexed keywords

8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; 9 (2 HYDROXY 3 NONYL)ADENINE; ALKALINE PHOSPHATASE; CASPASE 3; CILOSTAMIDE; CONNEXIN 43; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPYRIDAMOLE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE I INHIBITOR; PHOSPHODIESTERASE II INHIBITOR; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHODIESTERASE V; PHOSPHODIESTERASE VI; PHOSPHORIC ACID DERIVATIVE; ROLIPRAM; SPLEEN EXONUCLEASE; UNCLASSIFIED DRUG; VINPOCETINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CAMP RESPONSE ELEMENT; CELL FUNCTION; CELL LEVEL; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; ENZYMOLOGY; FUNCTIONAL PROTEOMICS; MALE; MESANGIUM CELL; MITOGENESIS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

1-METHYL-3-ISOBUTYLXANTHINE; 3',5'-CYCLIC-AMP PHOSPHODIESTERASES; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; MALE; MESANGIAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RESPONSE ELEMENTS;

EID: 33746067873     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706785     Document Type: Article

References (47)

1. AIZAWA, T., WEI, H., MIANO, J.M., ABE, J., BERK, B.C. & YAN, C. (2003). Role of phosphodiesterase 3 in NO/cGMP-mediated anti-inflammatory effects in vascular smooth muscle cells. Circ. Res., 93, 406-413.
2. BAILEY, J., PHILLIPS, R.J., POLLARD, A.J., GILMORE, K., ROBSON, S.C. & EUROPE-FINNER, G.N. (2002). Characterization and functional analysis of cAMP response element modulator protein and activating transcription factor 2 (ATF2) isoforms in the human myometrium during pregnancy and labor: identification of a novel ATF2 species with potent transactivation properties. J. Clin. Endocrinol. Metab., 87, 1717-1728.
3. BEAVO, J.A. (1995). Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev., 75, 725-748.
4. BEGANY, D.P., CARCILLO, J.A., HERZER, W.A., MI, Z. & JACKSON, E.K. (1996). Inhibition of type IV phosphodiesterase by Ro20-1724 attenuates endotoxin-induced acute renal failure. J. Pharmacol. Exp. Ther., 278, 37-41.
5. BERGER, J., HAUBER, J., HAUBER, R., GEIGER, R. & CULLEN, B.R. (1988). Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene, 66, 1-10.
6. CHANG, H.S., JEON, K.W., KIM, Y.H., CHUNG, I.Y. & PARK, C.S. (2000). Role of cAMP-dependent pathway in eosinophil apoptosis and survival. Cell. Immunol., 203, 29-38.
7. CHANSON, M., WHITE, M.M. & GARBER, S.S. (1996). cAMP promotes gap junctional coupling in T84 cells. Am. J. Physiol., 271, C533-C539.
8. CHENG, J., THOMPSON, M.A., WALKER, H.J., GRAY, C.E., DIAZ ENCARNACION, M.M., WARNER, G.M. & GRANDE, J.P. (2004). Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4. Am. J. Physiol. Renal. Physiol., 287, F940-F953.
9. CHINI, E.N., CHINI, C.C., BOLLIGER, C., JOUGASAKI, M., GRANDE, J.P., BURNETT Jr, J.C. & DOUSA, T.P. (1997b). Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int., 52, 917-925.
10. CHINI, C.C., CHINI, E.N., WILLIAMS, J.M., MATOUSOVIC, K. & DOUSA, T.P. (1994). Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Kidney Int., 46, 28-36.
11. CHINI, C.C., GRANDE, J.P., CHINI, E.N. & DOUSA, T.P. (1997a). Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis. J. Biol. Chem., 272, 9854-9859.
12. CHOUDHURY, G.G., BISWAS, P., GRANDALIANO, G., FOUQUERAY, B., HARVEY, S.A. & ABBOUD, H.E. (1994). PDGF-mediated activation of phosphatidylinositol 3 kinase in human mesangial cells. Kidney Int., 46, 37-47.
13. CRAVEN, P.A., STUDER, R.K., FELDER, J., PHILLIPS, S. & DERUBERTIS, F.R. (1997). Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes, 46, 671-681.
14. CULLEN, B.R. & MALIM, M.H. (1992). Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Methods Enzymol., 216, 362-368.
15. DOUSA, T.P. (1998). Signaling role of PDE isozymes in pathobiology of glomerular mesangial cells. Studies in vitro and in vivo. Cell Biochem. Biophys., 29, 19-34.
16. DOUSA, T.P. (1999). Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int., 55, 29-62.
17. DUFAU, M.L., TSURUHARA, T., HORNER, K.A., PODESTA, E. & CATT, K.J. (1977). Intermediate role of adenosine 3′:5′-cyclic monophosphate and protein kinase during gonadotropin-induced steroidogenesis in testicular interstitial cells. Proc. Natl. Acad. Sci. U.S.A., 74, 3419-3423.
18. GARG, U.C. & HASSID, A. (1989). Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am. J. Physiol., 257, F60-F66.
19. GLASS II, W.F., RADNIK, R.A., GARONI, J.A. & KREISBERG, J.I. (1988). Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells. J. Clin. Invest., 82, 1992-2000.
20. GOODENOUGH, D.A., GOLIGER, J.A. & PAUL, D.L. (1996). Connexins, connexons, and intercellular communication. Annu. Rev. Biochem., 65, 475-502.
21. HIRAMATSU, N., KASAI, A., MENG, Y., HAYAKAWA, K., YAO, J. & KITAMURA, M. (2005). Alkaline phosphatase vs luciferase as secreted reporter molecules in vivo. Anal. Biochem., 339, 249-256.
22. HIRAMATSU, N., KASAI, A., YAO, J., MENG, Y., TAKEDA, M., MAEDA, S. & KITAMURA, M. (2004). AP-1-independent sensitization to oxidative stress-induced apoptosis by proteasome inhibitors. Biochem. Biophys. Res. Commun., 316, 545-552.
23. HOUSLAY, M.D. & MILLIGAN, G. (1997). Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem. Sci., 22, 217-224.
24. ISHIKAWA, Y. & KITAMURA, M. (2000). Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int.. 58, 1078-1087.
25. KASAI, A., HIRAMATSU, N., MENG, Y., YAO, J., MAEDA, S. & KITAMURA, M. (2005). Fast-track DRESSA: a bioassay for fast, sensitive, and selective detection of halogenated and polycyclic aromatic hydrocarbons. Anal. Biochem., 337, 84-88.
26. KASAI, A., HIRAMATSU, N., MENG, Y., YAO, J., TAKEDA, M., MAEDA, S. & KITAMURA, M. (2004). DRESSA: biosensing of dioxin and dioxin-like chemicals using secreted alkaline phosphatase. Anal. Biochem., 335, 73-80.
27. KITAMURA, M., SUTO, T., YOKOO, T., SHIMIZU, F. & FINE, L.G. (1996). Transforming growth factor-β1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol., 156, 2964-2971.
28. KITAMURA, M., TAYLOR, S., UNWIN, R., BURTON, S., SHIMIZU, F. & FINE, L.G. (1994). Gene transfer into the rat renal glomerulus via a mesangial cell vector: site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J. Clin. Invest., 94, 497-505.
29. KREISBERG, J.I., VENKATACHALAM, M.A. & PATEL, P.Y. (1984). Cyclic AMP-associated shape change in mesangial cells and its reversal by prostaglandin E2. Kidney Int., 25, 874-879.
30. KUMAR, N.M. & GILULA, N.B. (1996). The gap junction communication channel. Cell. 84, 381-388.
31. MANDERSCHEID, M., PEREDA-FERNANDEZ, C. & PFEILSCHIFTER, J. (2002). Cyclic AMP increases rat inhibitor of apoptosis protein (RIAP1) mRNA in renal mesangial cells. Kidney Int., 61, 797-803.
32. MATOUSOVIC, K., GRANDE, J.P., CHINI, C.C., CHINI, E.N. & DOUSA, T.P. (1995). Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. J. Clin. Invest., 96, 401-410.
33. MENG, Y., KASAI, A., HIRAMATSU, N., HAYAKAWA, K., TAKEDA, M., SHIMIZU, F., KAWACHI, H., YAO, J. & KITAMURA, M. (2005a). Real-time monitoring of mesangial cell-macrophage cross-talk using SEAP in vitro and ex vivo. Kidney Int., 68, 886-893.
34. MENG, Y., KASAI, A., HIRAMATSU, N., HAYAKAWA, K., YAMAUCHI, K., TAKEDA, M., KAWACHI, H., SHIMIZU, F., YAO, J. & KITAMURA, M. (2005b). Continuous, noninvasive monitoring of local microscopic inflammation using a genetically engineered cell-based biosensor. Lab Invest, 85, 1429-1439.
35. MUHL, H., NITSCH, D., SANDAU, K., BRUNE, B., VARGA, Z. & PFEILSCHIFTER, J. (1996). Apoptosis is triggered by the cyclic AMP signalling pathway in renal mesangial cells. FEBS Lett., 382, 271-275.
36. OSINSKI, M.T., RAUCH, B.H. & SCHROR, K. (2001). Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A. Mol. Pharmacol., 59, 1044-1050.
37. ROGER, P.P., REUSE, S., MAENHAUT, C. & DUMONT, J.E. (1995). Multiple facets of the modulation of growth by cAMP. Vitam. Horm., 51, 59-191.
38. SAUSBIER, M., SCHUBERT, R., VOIGT, V., HIRNEISS, C., PFEIFER, A., KORTH, M., KLEPPISCH, T., RUTH, P. & HOFMANN, F. (2000). Mechanisms of NO/cGMP-dependent vasorelaxation. Circ. Res., 87, 825-830.
39. SHULZ, P.J., DICORLETO, P.E., SILVER, B.J. & ABBOUD, H.E. (1988). Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am. J. Physiol., 255, F674-F684.
40. TAM, F.W., SMITH, J., AGARWAL, S., KARKAR, A.M., MOREL, D., THOMPSON, E.M. & PUSEY, C.D. (2000). Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis. Nephron, 84, 58-66.
41. TENBROEK, E.M., LAMPE, P.D., SOLAN, J.L., REYNHOUT, J.K. & JOHNSON, R.G. (2001). Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP. J. Cell Biol., 155, 1307-1318.
42. TSUBOI, Y., SHANKLAND, S.J., GRANDE, J.P., WALKER, H.J., JOHNSON, R.J. & DOUSA, T.P. (1996). Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV. J. Clin. Invest., 98, 262-270.
43. USHER, L.R., LAWSON, R.A., GEARY, I., TAYLOR, C.J., BINGLE, C.D., TAYLOR, G.W. & WHYTE, M.K. (2002). Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J. Immunol., 168, 1861-1868.
44. YAO, J., HIRAMATSU, N., ZHU, Y., MORIOKA, T., TAKEDA, M., OITE, T. & KITAMURA, M. (2005). Nitric oxide-mediated regulation of connexin43 expression and gap junction intercellular communication in mesangial cells. J. Am. Soc. Nephrol., 16, 58-67.
45. YAO, J., KITAMURA, M., ZHU, Y., MENG, Y., KASAI, A., HIRAMATSU, N., MORIOKA, T., TAKEDA, M. & OITE, T. (2006). Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells. Am. J. Physiol. Renal. Physiol., 290, F1083-F1093.
46. YAO, J., MORIOKA, T. & OITE, T. (2000). PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3-kinase in mesangial cells. Kidney Int., 57, 1915-1926.
47. YAO, J., SCHOECKLMANN, H.O., PROLS, F., GAUER, S. & STERZEL, R.B. (1998). Exogenous nitric oxide inhibits mesangial cell adhesion to extracellular matrix components. Kidney Int., 53, 598-608.